You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
Biological Activity for Auranofin
Auranofin is an inhibitor of thioredoxin reductase (TrxR) (IC50 = 20 nM; Ki = 4 nM for the NADPH-reduced form of human cytosolic TrxR). Thought to induce the mitochondrial permeability transition via inhibition of mitochondrial TrxR. Also exhibits anti-inflammatory and immunosuppressive activities; inhibits 5-lipoxygenase at high concentrations and stimulates LTA hydrolase at low concentrations. Also inhibits SARS-CoV-2 infection in Huh7 cell line (IC50 = 1.4 μM)
Technical Data for Auranofin
|Storage||Store at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for Auranofin
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions for Auranofin
The following data is based on the product molecular weight 678.48. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.47 mL||7.37 mL||14.74 mL|
|5 mM||0.29 mL||1.47 mL||2.95 mL|
|10 mM||0.15 mL||0.74 mL||1.47 mL|
|50 mM||0.03 mL||0.15 mL||0.29 mL|
References for Auranofin
References are publications that support the biological activity of the product.
Kim et al (2007) Auranofin blocks interleukin-6 signalling by inhibiting phosphorylation of JAK1 and STAT3. Immunology 122 607 PMID: 17645497
Rigobello et al (2002) Induction of mitochondrial permeability transition by auranofin, a gold(I)-phosphine derivative. Br.J.Pharmacol. 136 1162 PMID: 12163349
Gromer et al (1998) Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. J.Biol.Chem. 273 20096 PMID: 9685351
Betts et al (1990) Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils. Biochem.Pharmacol. 39 1233 PMID: 2157444
Rothan et al (2020) The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells. Virology 547 7 PMID: 32442105
If you know of a relevant reference for Auranofin, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Auranofin, Auranofin supplier, antirheumatic, antiarthritic, arthritis, mitochondrial, permeability, pore, transition, mpt, inducers, anti-inflammatory, anti-inflammatories, immunosuppressive, immunosuppressants, thioredoxin, reductase, TrxR, inhibitors, inhibits, SARS-CoV-2, infection, MPTP, Thioredoxin, Reductases, COVID-19, Coronavirus, 4600, Tocris Bioscience
1 Citation for Auranofin
Citations are publications that use Tocris products. Selected citations for Auranofin include:
Tsai et al (2015) Zeta Inhibitory Peptide Disrupts Electrostatic Interactions That Maintain Atypical Protein Kinase C in Its Active Conformation on the Scaffold p62. J Biol Chem 290 21845 PMID: 26187466
Do you know of a great paper that uses Auranofin from Tocris? Please let us know.
Reviews for Auranofin
There are currently no reviews for this product. Be the first to review Auranofin and earn rewards!
Have you used Auranofin?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Programmed Cell Death Poster
There are two currently recognized forms of programmed cell death: apoptosis and necroptosis. This poster summarizes the signaling pathways involved in apoptosis, necroptosis and cell survival following death receptor activation, and highlights the influence of the molecular switch, cFLIP, on cell fate.